BlackRock, Inc. 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-07 12:29 pm Sale | 2024-02-29 | 13G | Alpine Immune Sciences, Inc. ALPN | BlackRock Inc. BLK | 3,026,330 4.600% | -32,168 (-1.05%) | Filing |
| 2024-02-02 3:57 pm Purchase | 2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | BlackRock Inc. BLK | 3,058,498 5.300% | 3,058,498 (New Position) | Filing |